+464.5%
MRNA vs GLXY
+15.1%
+449.4%
-35.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GLXY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | +2.7% | -6.3% | -4.5% |
| 7D | -9.0% | +15.5% | -24.5% | -13.6% |
| 30D | +137.2% | +34.1% | +103.1% | +115.2% |
| 3M | +194.8% | -11.3% | +206.2% | +190.4% |
| 6M | +167.2% | +31.6% | +135.6% | +136.9% |
| YTD | +375.9% | +21.0% | +354.9% | +320.0% |
| 1Y | +465.2% | +11.7% | +453.5% | +402.4% |
| All | +464.5% | +15.1% | +449.4% | +390.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GLXY.
Daily Out/Under-Performance
Portfolio return minus GLXY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLXY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GLXY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling